Smart Integrated Health Promotion Program

May 15, 2023 updated by: National Yang Ming University

Smart Integrated Health Promotion Program and Health Behavior for Older Adult

health promotion behavior is important in older adults.The purpose of this study is to examine the efficacy of smart integrated health promotion intervention among middle age adults and older adults in community.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

There very limited research focused on leisure activity, nutrition status, quality of life and subjective well-being. In addition, there is lack of research develop smart integrated health promotion intervention to enhance well-being for middle age adults older adults in community and examine the efficacy of the intervention. The purpose of this study is to examine the efficacy of smart integrated health promotion intervention among middle age adults and older adults in community .

Study Type

Interventional

Enrollment (Anticipated)

160

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Taichung, Taiwan, 632
        • Recruiting
        • WISON Pharmacy
        • Contact:
          • George Liao
          • Phone Number: 886-987-817-823

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

46 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

(1) age over 50 years

Exclusion Criteria:

  1. those who could not understanding protocol or communication with search nurses;
  2. or with cognitive impairment or mental disorders;
  3. or advance cancer;
  4. or have been myocardial infarction;
  5. or congestive heart failure was excluded.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: contrl
provide an irregular nutrition counselling to case by nutritionist
Experimental: intervention
Multi-domain intervention included exercise,cognitive training and diet education was conducted for five hours per week in the first month, second month and third month.
Multi-domain intervention 120 minutes cognitive training, 120 ~180 minutes physical exercise per weeks, and 60 minutes diet nutrition education per month

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes from baseline life quality at 3, 6, 9 month
Time Frame: baseline, 3, 6, 9 month
measured by the EuroQol- 5 Dimension (EQ-5D), score range 0-1,The higher the score, the better the quality of life
baseline, 3, 6, 9 month
Changes from baseline life quality at 3, 6, 9 month
Time Frame: baseline, 3, 6, 9 month
measured by the subjective well-being scale, score range 10-50, The higher the score, the better the quality of life
baseline, 3, 6, 9 month

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes from baseline one touch blood sugar in mg/dl at 3, 6, 9 month
Time Frame: baseline, 3, 6, 9 month
Changes from baseline one touch blood sugar in mg/dl at 3, 6, 9 month
baseline, 3, 6, 9 month
Changes from baseline one touch urine acid in mg/dl at 3, 6, 9 month
Time Frame: baseline, 3, 6, 9 month
Changes from baseline one touch urine acid in mg/dl at 3, 6, 9 month
baseline, 3, 6, 9 month
Changes from baseline one touch total cholesterol in mg/dl at 3, 6, 9 month
Time Frame: baseline, 3, 6, 9 month
Changes from baseline one touch total cholesterol in mg/dl at 3, 6, 9 month
baseline, 3, 6, 9 month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Heng-Hsin Tung, PhD, National Yang Ming University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 18, 2022

Primary Completion (Anticipated)

February 17, 2024

Study Completion (Anticipated)

February 17, 2024

Study Registration Dates

First Submitted

June 6, 2022

First Submitted That Met QC Criteria

June 6, 2022

First Posted (Actual)

June 9, 2022

Study Record Updates

Last Update Posted (Actual)

May 17, 2023

Last Update Submitted That Met QC Criteria

May 15, 2023

Last Verified

February 1, 2023

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Quality of Life

Clinical Trials on health promotion program

Subscribe